MPS Powered by Eureka

Demystifying COVID-19: Understanding the disease, Its Diagnosis and Treatment


Density Matrix in Quantum Physics


Design and Analysis of RF MEMS Switches for Reconfigurable Devices


Design optimization of energy applications through heat transfer systems


Detection and Analysis of COVID-19 Cases Using Machine Learning Techniques: A Handbook


Development and Prospective Applications of Nanoscience and Nanotechnology


DFT Based Studies on Molecular Systems


Diabesity: A Multidisciplinary Approach


DIABETES AND THE EYE: LATEST CONCEPTS AND PRACTICES


Differential and Integral Calculus - Theory and Cases


Diversity of Natural Remedy Sources in Kodagu region of India


Drug Delivery Letters

ISSN: 2210-3031 (Print)
eISSN: 2210-304X (Online)

Drug Delivery Letters publishes short papers and mini-reviews in all important aspects of drug delivery, gene delivery, and drug targeting. Short papers report seminal results and research approaching conclusion of importance in the field. The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The manuscript submission process is fully electronic to ensure rapid publication of research results.

Drug Metabolism Letters

ISSN: 1872-3128 (Print)
eISSN: 1874-0758 (Online)

Drug Metabolism Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and disposition. In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates.